SCYNEXIS Inc (SCYX)
1.73
0.00 (0.00%)
USD |
NASDAQ |
May 02, 12:14
SCYNEXIS Price to Book Value: 0.8952 for May 2, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 01, 2024 | 0.8952 |
| April 30, 2024 | 0.8745 |
| April 29, 2024 | 0.9417 |
| April 26, 2024 | 0.7969 |
| April 25, 2024 | 0.7606 |
| April 24, 2024 | 0.7762 |
| April 23, 2024 | 0.802 |
| April 22, 2024 | 0.7451 |
| April 19, 2024 | 0.7451 |
| April 18, 2024 | 0.727 |
| April 17, 2024 | 0.7348 |
| April 16, 2024 | 0.7296 |
| April 15, 2024 | 0.7606 |
| April 12, 2024 | 0.7477 |
| April 11, 2024 | 0.8279 |
| April 10, 2024 | 0.8176 |
| April 09, 2024 | 0.8434 |
| April 08, 2024 | 0.8434 |
| April 05, 2024 | 0.8848 |
| April 04, 2024 | 0.8693 |
| April 03, 2024 | 0.9314 |
| April 02, 2024 | 0.7503 |
| April 01, 2024 | 0.771 |
| March 28, 2024 | 0.7606 |
| March 27, 2024 | 0.7374 |
| Date | Value |
|---|---|
| March 26, 2024 | 0.7192 |
| March 25, 2024 | 0.7399 |
| March 22, 2024 | 0.7192 |
| March 21, 2024 | 0.7244 |
| March 20, 2024 | 0.7296 |
| March 19, 2024 | 0.7451 |
| March 18, 2024 | 0.7451 |
| March 15, 2024 | 0.7503 |
| March 14, 2024 | 0.7762 |
| March 13, 2024 | 0.7917 |
| March 12, 2024 | 0.8279 |
| March 11, 2024 | 0.8331 |
| March 08, 2024 | 0.859 |
| March 07, 2024 | 0.8745 |
| March 06, 2024 | 0.8641 |
| March 05, 2024 | 0.8538 |
| March 04, 2024 | 0.8434 |
| March 01, 2024 | 0.8383 |
| February 29, 2024 | 0.8261 |
| February 28, 2024 | 0.8669 |
| February 27, 2024 | 0.8669 |
| February 26, 2024 | 0.8771 |
| February 23, 2024 | 0.8567 |
| February 22, 2024 | 0.8414 |
| February 21, 2024 | 0.8669 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.631
Minimum
Nov 29 2023
30.30
Maximum
Mar 30 2023
5.840
Average
5.223
Median
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | 1.904 |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.7880 |
| Theriva Biologics Inc | 0.1851 |
| Oragenics Inc | 3.043 |
Price to Book Value Related Metrics
| PE Ratio | 1.331 |
| PS Ratio | 0.5972 |
| Price to Free Cash Flow | 1.391 |
| Price | 1.73 |
| Earnings Yield | 75.14% |
| Market Cap | 65.31M |
| Operating PE Ratio | 1.152 |
| Normalized PE Ratio | 1.244 |